Maureen Kelley

Maureen Kelley

Auto-generated profile, based on publicly available information

Maureen Kelley

University of Washington School of Medicine

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2012 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
MKMaureen C Kelley
Maureen C Kelley
STSusan B Trinidad
Susan B Trinidad
In the United States, an estimated 70 stillbirths occur each day, on average 25,000 each year. Research into the prevalence and causes of stillbirth is ongoing, but meanwhile, many parents suffer this devastating loss, largely in silence, due to persistent stigma and taboo; and many health providers report feeling ill equipped to support grieving parents. Interventions to address bereavement after neonatal death are increasingly common in U.S. hospitals, and there is growing data on the nature of parent bereavement after a stillbirth. However, further research is needed to evaluate supportive interventions and to investigate the parent-clinician encounter during hospitalization following a stillbirth. Qualitative inquiry offers opportunities to better understand the lived experience of parents against the backdrop of clinicians’ beliefs, intentions, and well-meaning efforts to support grieving parents.

19 May 2015 in Annals of Internal Medicine
Verified
Journal Article
Closed access
MCMildred K. Cho
Mildred K. Cho
DMDavid Magnus
David Magnus
MCMelissa Constantine
Melissa Constantine
SLSandra Soo-Jin Lee
Sandra Soo-Jin Lee
MKMaureen Kelley
Maureen Kelley
BWBenjamin S. Wilfond
Benjamin S. Wilfond
Should informed consent for participants in research that compares the effectiveness of standard medical practices include notification of the potential risks of those practices? This survey of 109... Background: The U.S. Office for Human Research Protections has proposed that end points of randomized trials comparing the effectiveness of standard medical practices are risks of research that wou...

25 August 2015 in The American Journal of Bioethics
Verified
Journal Article
Closed access
MKMaureen Kelley
Maureen Kelley
CJCyan James
Cyan James
SKStephanie Alessi Kraft
Stephanie Alessi Kraft
DKDiane Korngiebel
Diane Korngiebel
IWIsabelle Wijangco
Isabelle Wijangco
SLSandra Lee
Sandra Lee
We conducted focus groups to assess patient attitudes toward research on medical practices in the context of usual care. We found that patients focus on the implications of this research for their relationship with and trust in their physicians. Patients view research on medical practices as separate from usual care, demanding dissemination of information and in most cases, individual consent. Patients expect information about this research to come through their physician, whom they rely on to identify and filter associated risks. In general, patients support this research, but worry that participation in research involving randomization may undermine individualized care that acknowledges their unique medical histories. These findings suggest the need for public education on variation in practice among physicians and the need for a collaborative approach to the governance of research on medical practices that addresses core values of trust, transparency, and partnership.

3 September 2018 in International Health
Verified
Journal Article
Open access
PDF file
GDGonzalo Domingo
Gonzalo Domingo
NANicole Advani
Nicole Advani
ASAri W Satyagraha
Ari W Satyagraha
CSCarol H Sibley
Carol H Sibley
ERElizabeth Rowley
Elizabeth Rowley
MKMaureen Kelley
Maureen Kelley
Glucose-6-phosphate dehyrdgoenase (G6PD) deficiency is a common X-linked genetic trait, with an associated enzyme phenotype, whereby males are either G6PD deficient or normal, but females exhibit a broader range of G6PD deficiencies, ranging from severe deficiency to normal. Heterozygous females typically have intermediate G6PD activity. G6PD deficiency has implications for the safe treatment for Plasmodium vivax malaria. Individuals with this deficiency are at greater risk of serious adverse events following treatment with the only curative class of anti-malarials, 8-aminoquinolines, such as primaquine. Quantitative diagnostic tests for G6PD deficiency are complex and require sophisticated laboratories. The commonly used qualitative tests, do not discriminate intermediate G6PD activities. This has resulted in poor understanding of the epidemiology of G6PD activity in females and its corresponding treatment ramifications. New simple-to-use quantitative tests, and a momentum to eliminate malaria, create an opportunity to address this knowledge gap. While this will require additional resources for clinical studies, adequate operational research, and appropriate pharmacovigilance, the health benefits from this investment go beyond the immediate intervention for which the G6PD status is first diagnosed.

1 July 2020 in The Lancet Global Health
Verified
Journal Article
Open access
MKMaureen Kelley
Maureen Kelley
RFRashida A Ferrand
Rashida A Ferrand
KMKui Muraya
Kui Muraya
SCSimukai Chigudu
Simukai Chigudu
SMSassy Molyneux
Sassy Molyneux
EBEdwine Barasa
Edwine Barasa

1 November 2019 in The Lancet Global Health
Verified
Journal Article
Open access
KIKiersten Israel-Ballard
Kiersten Israel-Ballard
JCJessica Cohen
Jessica Cohen
KMKimberly Mansen
Kimberly Mansen
MPMichael Parker
Michael Parker
CECyril Engmann
Cyril Engmann
PZPaul Zambrano
Paul Zambrano